ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MALCOLM ROLAND M.D.

Neurology

2,302

$410K

242
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$178
Average prescription price

Avg: $145

JOSE FERNANDEZ MD

Neurology

2,300

$252K

242
125 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $145

NAMITA ARORA M.D.

Neurology

2,155

$308K

170
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $145

ANGELA CHANDLER M.D.

Neurology

2,111

$836K

214
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$396
Average prescription price

Avg: $145

DIANE ROSS M.D.

Neurology

2,099

$472K

189
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$225
Average prescription price

Avg: $145

DONNA HARRINGTON M.D.

Neurology

2,007

$358K

349
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$178
Average prescription price

Avg: $145

JOSEPH JACKSON M.D.

Neurology

1,613

$120K

174
78 are 65+

38%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $145

ROBERT OZON MD

Neurology

1,575

$16.5K

182
29 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

76%
patients receiving schedule three controlled substances

Avg: 10%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

1%
prescriptions for brand name drugs

Avg: 24%

$10
Average prescription price

Avg: $145

KRISHNA GOLI M.D.

Neurology

1,510

$154K

271
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $145

WILLIAM OAKES M.D.

Neurology

1,497

$285K

280
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$191
Average prescription price

Avg: $145

MARK FLETCHER M.D.

Neurology

1,476

$211K

159
82 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $145

ANCEL TIPTON M.D.

Neurology

1,161

$116K

84
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $145

JINAL SHAH M.D.

Neurology

1,072

$153K

179
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 10%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $145

JUSTIN GRAFF M.D.

Neurology

1,037

$264K

147
80 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$254
Average prescription price

Avg: $145

SAMUEL NEWELL M.D.

Neurology

957

$164K

163
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$172
Average prescription price

Avg: $145

GABRIELLA SZATMARY MD

Neurology

950

$169K

119
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$178
Average prescription price

Avg: $145

XIAOHONG SI

Neurology

927

$220K

118
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 24%

$237
Average prescription price

Avg: $145

MITCHELL MYERS M.D.

Neurology

873

$50.3K

117
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $145

NATHANIEL LAWSON M.D.

Neurology

864

$93.1K

99
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$108
Average prescription price

Avg: $145

JIMMY WOLFE M.D.

Neurology

809

$88.2K

134
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $145

UNIVERSITY NEUROLOGY GROUP, PLLC

Neurology

693

$62.7K

102
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$91
Average prescription price

Avg: $145

MOHAMMAD AHMED M.D.

Neurology

397

$17.9K

126
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $145

GEORGE WILKERSON MD

Neurology

376

$24.9K

63
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $145

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank